SALT LAKE CITY, Oct. 13, 2009 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (Nasdaq:MYGN) today announced that it will release its fiscal 2010 first quarter financial results at the close of market on Tuesday, November 3, 2009.

The Company will host a conference call on Tuesday, November 3, at 4:30 p.m. Eastern to review the financial results. Participating on the call will be: Peter D. Meldrum, President and Chief Executive Officer; Jim Evans, Chief Financial Officer; and, Gregory C. Critchfield, M.D., President of Myriad Genetic Laboratories, Inc.

To participate on the call, callers may dial (800) 785-6380 or (212) 231-2906 approximately 10-15 minutes before the start of the call. All callers will be asked to reference reservation number 21438735.

The conference call also will be available to interested parties through a live audio Internet broadcast at www.myriad.com.

A replay of the call will be available beginning two hours after the end of the call until seven days following the call and may be accessed by dialing (800) 633-8625 or (402) 977-9141, and entering the reservation number 21438735.

Myriad Genetics, Inc. is a healthcare company focused on the development and marketing of novel molecular diagnostic products. Myriad's news and other information are available on the company's Web site at www.myriad.com. MYGN-F

The Myriad Genetics, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=6336

CONTACT:  Myriad Genetics, Inc.
          Suzanne Barton, Director, Investor Relations
          (801) 584-1138
          sbarton@myriad.com